McGinn CJ - Search Results

1

McGinn CJ, Shewach DS, Lawrence TS. McGinn CJ, et al. J Natl Cancer Inst. 1996 Sep 4;88(17):1193-203. doi: 10.1093/jnci/88.17.1193. J Natl Cancer Inst. 1996. PMID: 8780628 Review.

2

The mechanism of action of radiosensitization of conventional chemotherapeutic agents.

Lawrence TS, Blackstock AW, McGinn C. Lawrence TS, et al. Semin Radiat Oncol. 2003 Jan;13(1):13-21. doi: 10.1053/srao.2003.50002. Semin Radiat Oncol. 2003. PMID: 12520460 Review.

3

On the development of gemcitabine-based chemoradiotherapy regimens in pancreatic cancer.

McGinn CJ, Lawrence TS, Zalupski MM. McGinn CJ, et al. Cancer. 2002 Aug 15;95(4 Suppl):933-40. doi: 10.1002/cncr.10754. Cancer. 2002. PMID: 12209674 Free article. Review.

4

Radiosensitization by gemcitabine.

Lawrence TS, Eisbruch A, McGinn CJ, Fields MT, Shewach DS. Lawrence TS, et al. Among authors: mcginn cj. Oncology (Williston Park). 1999 Oct;13(10 Suppl 5):55-60. Oncology (Williston Park). 1999. PMID: 10550827 Free article. Review.

5

Recent advances in the use of radiosensitizing nucleosides.

McGinn CJ, Lawrence TS. McGinn CJ, et al. Semin Radiat Oncol. 2001 Oct;11(4):270-80. doi: 10.1053/srao.2001.26002. Semin Radiat Oncol. 2001. PMID: 11677652 Review.

6

Concurrent chemoradiotherapy with gemcitabine and cisplatin for pancreatic cancer: from the laboratory to the clinic.

Symon Z, Davis M, McGinn CJ, Zalupski MM, Lawrence TS. Symon Z, et al. Among authors: mcginn cj. Int J Radiat Oncol Biol Phys. 2002 May 1;53(1):140-5. doi: 10.1016/s0360-3016(01)02790-0. Int J Radiat Oncol Biol Phys. 2002. PMID: 12007952

7

Adjuvant therapy in pancreatic cancer: Phase I trial of radiation dose escalation with concurrent full-dose gemcitabine.

Allen AM, Zalupski MM, Robertson JM, Eckhauser FE, Simone D, Brown D, Hejna G, Normolle D, Lawrence TS, McGinn CJ. Allen AM, et al. Among authors: mcginn cj. Int J Radiat Oncol Biol Phys. 2004 Aug 1;59(5):1461-7. doi: 10.1016/j.ijrobp.2004.01.015. Int J Radiat Oncol Biol Phys. 2004. PMID: 15275733 Clinical Trial.

8

Phase I trial of radiation dose escalation with concurrent weekly full-dose gemcitabine in patients with advanced pancreatic cancer.

McGinn CJ, Zalupski MM, Shureiqi I, Robertson JM, Eckhauser FE, Smith DC, Brown D, Hejna G, Strawderman M, Normolle D, Lawrence TS. McGinn CJ, et al. J Clin Oncol. 2001 Nov 15;19(22):4202-8. doi: 10.1200/JCO.2001.19.22.4202. J Clin Oncol. 2001. PMID: 11709563 Clinical Trial.

9

A phase I trial of hepatic arterial bromodeoxyuridine and conformal radiation therapy for patients with primary hepatobiliary cancers or colorectal liver metastases.

Robertson JM, McGinn CJ, Walker S, Marx MV, Kessler ML, Ensminger WD, Lawrence TS. Robertson JM, et al. Among authors: mcginn cj. Int J Radiat Oncol Biol Phys. 1997 Dec 1;39(5):1087-92. doi: 10.1016/s0360-3016(97)00550-6. Int J Radiat Oncol Biol Phys. 1997. PMID: 9392548 Clinical Trial.

10

Surgical resection following radiation therapy with concurrent gemcitabine in patients with previously unresectable adenocarcinoma of the pancreas.

Ammori JB, Colletti LM, Zalupski MM, Eckhauser FE, Greenson JK, Dimick J, Lawrence TS, McGinn CJ. Ammori JB, et al. Among authors: mcginn cj. J Gastrointest Surg. 2003 Sep-Oct;7(6):766-72. doi: 10.1016/s1091-255x(03)00113-6. J Gastrointest Surg. 2003. PMID: 13129554

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

47 results

Search Page

Filters